Core Scientific, Inc.
CORZ
$14.53
$0.402.83%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.58% | -2,568.90% | -433.50% | -156.39% | 5.49% |
| Total Depreciation and Amortization | -11.87% | 6.46% | 24.55% | -9.45% | -33.37% |
| Total Amortization of Deferred Charges | 219.45% | 241.93% | 399.47% | 223.36% | -41.62% |
| Total Other Non-Cash Items | 31.16% | 2,427.32% | 3,115.02% | 4,384.47% | 114.11% |
| Change in Net Operating Assets | -56.19% | -720.19% | -274.03% | -121.32% | -119.29% |
| Cash from Operations | -74.43% | -129.51% | -34.12% | -68.13% | -50.42% |
| Capital Expenditure | -445.64% | -225.67% | -487.59% | 46.22% | 66.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,007.38% | -796.55% | 72.27% | -100.00% | 40.34% |
| Cash from Investing | -665.81% | -373.40% | -3,077.30% | 55.79% | 75.84% |
| Total Debt Issued | -- | -- | -- | 891.01% | -- |
| Total Debt Repaid | -373.19% | -389.56% | -596.22% | -634.81% | 18.82% |
| Issuance of Common Stock | -90.70% | -90.64% | -- | 127.24% | 121.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -123.15% | -123.15% | -- | 190.70% | 531.77% |
| Cash from Financing | 13,454.72% | 6,989.02% | 1,935.58% | 1,630.71% | 130.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,280.14% | 1,199.24% | 4,292.19% | 621.92% | 131.93% |